Your browser doesn't support javascript.
loading
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
Rocconi, Rodney P; Grosen, Elizabeth A; Ghamande, Sharad A; Chan, John K; Barve, Minal A; Oh, Jonathan; Tewari, Devansu; Morris, Peter C; Stevens, Erin E; Bottsford-Miller, Justin N; Tang, Min; Aaron, Phylicia; Stanbery, Laura; Horvath, Staci; Wallraven, Gladice; Bognar, Ernest; Manning, Luisa; Nemunaitis, John; Shanahan, David; Slomovitz, Brian M; Herzog, Thomas J; Monk, Bradley J; Coleman, Robert L.
Afiliación
  • Rocconi RP; Division of Gynecologic Oncology, University of South Alabama-Mitchell Cancer Institute, Mobile, AL, USA.
  • Grosen EA; Department of Obstetrics and Gynecology, Cancer Care Northwest, Spokane, WA, USA.
  • Ghamande SA; Section of Gynecologic Oncology, Augusta University, Augusta, GA, USA.
  • Chan JK; Division of Gynecologic Oncology, California Pacific/Palo Alto Medical Foundation, Sutter Center Research Institute, San Francisco, CA, USA.
  • Barve MA; Department of Oncology, Mary Crowley Cancer Research Centers, Dallas, TX, USA; Department of Oncology, Texas Oncology, Dallas, TX, USA.
  • Oh J; Department of Oncology, Texas Oncology, Dallas, TX, USA.
  • Tewari D; Department of Obstetrics and Gynecology, Kaiser Permanente, Irvine, CA, USA.
  • Morris PC; Division of Gynecologic Oncology, Nebraska Methodist Hospital, Omaha, NE, USA.
  • Stevens EE; Department of Gynecologic Oncology, Billings Clinic, Billings, MT, USA.
  • Bottsford-Miller JN; Department of Gynecologic Oncology, Billings Clinic, Billings, MT, USA.
  • Tang M; Stats Department, StatBeyond Consulting, Irvine, CA, USA.
  • Aaron P; Department of Medical Affairs, Gradalis, Carollton, TX, USA.
  • Stanbery L; Department of Medical Affairs, Gradalis, Carollton, TX, USA.
  • Horvath S; Department of Site Research, Gradalis, Carollton, TX, USA.
  • Wallraven G; Department of Clinical and Regulatory Operations, Gradalis, Carollton, TX, USA.
  • Bognar E; Department of CMC Operations, Gradalis, Carollton, TX, USA; Department of CMC Operations, Gradalis, Carollton, TX, USA; Department of CMC Operations, Gradalis, Carollton, TX, USA.
  • Manning L; Department of Medical Affairs, Gradalis, Carollton, TX, USA.
  • Nemunaitis J; Department of Medical Affairs, Gradalis, Carollton, TX, USA. Electronic address: jnemunaitis@gradalisinc.com.
  • Shanahan D; Management Department, Gradalis, Carollton, TX, USA; Management Department, Gradalis, Carollton, TX, USA; Management Department, Gradalis, Carollton, TX, USA.
  • Slomovitz BM; Department of Obstetrics and Gynecology, Broward Health, Fort Lauderdale, FL, USA; Department of Obstetrics and Gynecology, Florida International University, Miami, FL, USA.
  • Herzog TJ; Department of Obstetrics and Gynecology, University of Cincinnati Cancer Center, Cincinnati, OH, USA.
  • Monk BJ; Department of Obstetrics and Gynecology, Arizona Oncology, Phoenix, AZ, USA.
  • Coleman RL; US Oncology Research, The Woodlands, TX, USA.
Lancet Oncol ; 21(12): 1661-1672, 2020 12.
Article en En | MEDLINE | ID: mdl-33271095
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Carcinoma Endometrioide / Vacunas contra el Cáncer Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Carcinoma Endometrioide / Vacunas contra el Cáncer Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido